TB progress threatened by global rise of multidrug resistance

By Australian Hospital + Healthcare Bulletin Staff
Saturday, 15 April, 2017

Adobestock 34827340

Tuberculosis (TB) kills more people each year than any other infectious disease. New antibiotics are becoming available for the first time but without accurate diagnostics, clear treatment guidelines and improved control efforts, their effectiveness could be rapidly lost.

The rise of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB threatens to derail decades of progress in controlling the disease. In most regions of the world, drug-resistant TB is now predominantly caused by transmission, with an estimated 95.9% of new cases infected with MDR-TB strains due to the bacteria spreading from one person to the next.

Dr David W Dowdy, Johns Hopkins Bloomberg School of Public Health, USA, believes we will see either an unprecedented drug-resistant TB epidemic or a reversal of the global problem. “The difference between these two outcomes lies less with the pathogen and more with us as a global tuberculosis control community and whether we have the political will to prioritise a specific response to the disease. Drug-resistant tuberculosis is not standing still; neither can we,” he said.

The Lancet Respiratory Medicine.

Image credit: ©stock.adobe.com/au/anandkrish16

Related News

Warning: Respiratory infections can trigger a heart attack

The risk of having a heart attack is 17 times higher in the seven days following a respiratory...

More Australians going private in hospitals — but what's the effect on waiting times?

A new report from the Australian Institute of Health and Welfare shows that more patients are...

Doctor bias may lead to low-value interventions

Doctors should be aware that psychological factors could lead them to suggest medical...

  • All content Copyright © 2017 Westwick-Farrow Pty Ltd